Allogene Therapeutics - 53 Year Dividend History | ALLO

Historical dividend payout and yield for Allogene Therapeutics (ALLO) since 1971. The current TTM dividend payout for Allogene Therapeutics (ALLO) as of May 17, 2024 is $0.00. The current dividend yield for Allogene Therapeutics as of May 17, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.514B $0.000B
Allogene Therapeutics, Inc. is a clinical-stage immuno-oncology company, primarily focused on the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer.?
Stock Name Country Market Cap PE Ratio